Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD

  • Megha Verma,
  • David Beaulieu-Abdelahad,
  • Ghania Ait-Ghezala,
  • Rena Li,
  • Fiona Crawford,
  • Michael Mullan,
  • Daniel Paris
  • Article
  • Metrics
  • Comments
  • Media Coverage

The following information is missing from the Funding section: This study was also funded by the Roskamp Foundation.

Reference

  1. 1. Verma M, Beaulieu-Abdelahad D, Ait-Ghezala G, Li R, Crawford F, Mullan M, et al. (2015) Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. PLoS ONE 10(5): e0128224. pmid:26010758

Citation: Verma M, Beaulieu-Abdelahad D, Ait-Ghezala G, Li R, Crawford F, Mullan M, et al. (2015) Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. PLoS ONE 10(7): e0134776. https://doi.org/10.1371/journal.pone.0134776

Published: July 31, 2015

Copyright: © 2015 Verma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited